NCT00647972View on ClinicalTrials.gov

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

PHASE1TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2003

Conditions
Healthy
Interventions
DRUG

Olanzapine Tablets 20 mg

20mg, single dose fasting

DRUG

Zyprexa® Tablets 20 mg

20mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647972 - Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg | Biotech Hunter | Biotech Hunter